1. Home
  2. GKOS vs RYAN Comparison

GKOS vs RYAN Comparison

Compare GKOS & RYAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • RYAN
  • Stock Information
  • Founded
  • GKOS 1998
  • RYAN 2010
  • Country
  • GKOS United States
  • RYAN United States
  • Employees
  • GKOS N/A
  • RYAN N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • RYAN Specialty Insurers
  • Sector
  • GKOS Health Care
  • RYAN Finance
  • Exchange
  • GKOS Nasdaq
  • RYAN Nasdaq
  • Market Cap
  • GKOS 7.4B
  • RYAN 8.5B
  • IPO Year
  • GKOS 2015
  • RYAN 2021
  • Fundamental
  • Price
  • GKOS $145.90
  • RYAN $65.33
  • Analyst Decision
  • GKOS Strong Buy
  • RYAN Buy
  • Analyst Count
  • GKOS 13
  • RYAN 12
  • Target Price
  • GKOS $143.00
  • RYAN $73.50
  • AVG Volume (30 Days)
  • GKOS 496.0K
  • RYAN 798.8K
  • Earning Date
  • GKOS 11-04-2024
  • RYAN 10-30-2024
  • Dividend Yield
  • GKOS N/A
  • RYAN 0.67%
  • EPS Growth
  • GKOS N/A
  • RYAN 53.91
  • EPS
  • GKOS N/A
  • RYAN 0.77
  • Revenue
  • GKOS $360,347,000.00
  • RYAN $2,324,982,000.00
  • Revenue This Year
  • GKOS $22.68
  • RYAN $26.22
  • Revenue Next Year
  • GKOS $24.98
  • RYAN $20.37
  • P/E Ratio
  • GKOS N/A
  • RYAN $84.52
  • Revenue Growth
  • GKOS 18.70
  • RYAN 20.14
  • 52 Week Low
  • GKOS $74.75
  • RYAN $41.57
  • 52 Week High
  • GKOS $147.65
  • RYAN $75.97
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 58.40
  • RYAN 28.85
  • Support Level
  • GKOS $137.60
  • RYAN $66.83
  • Resistance Level
  • GKOS $147.50
  • RYAN $67.85
  • Average True Range (ATR)
  • GKOS 4.74
  • RYAN 1.51
  • MACD
  • GKOS 0.45
  • RYAN -0.96
  • Stochastic Oscillator
  • GKOS 87.80
  • RYAN 2.23

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

About RYAN Ryan Specialty Holdings Inc.

Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Share on Social Networks: